Last week, we highlighted two new publications using Neuromics fetal bovine serum (FBS). Well, it took no time for our bio-reagents to appear in newly released publications again. Three more publications featuring Neuromics products were published.

In the first study, scientists at the University of Minnesota cultured our human colorectal cancer associated fibroblasts (CAFs) (cat. CAF115) in liver cancer research. The investigators used various cell and mouse models to explore how CAFs are activated to promote metastasis. Read the complete publication here.

The second citation focused on a researcher at Middle East Technical University in Ankara, Turkey, utilizing Neuromics type I rat tendon collagen (4 mg/ml) (cat. TY002) to build a 3D organoid breast cancer model. You can learn more here.

Lastly, investigators at Augusta University released a study demonstrating that a saline spray containing Epigallocatechin-3-gallate-palmitate (EC16) nanoformulations is an effective solution to treat COVID-19 in the nasal cavity. The study used Neuromics Premium Imported FBS (cat. FBS002) to culture several cell lines and primary cells. Check it out here.

As you can see, Neuromics reagents continue to support a wide range of research and projects. Our solutions provide reliability, fair pricing, and consistency. We suggest you check out all our products, including human cells, specialized media, FBS, primary antibodies, protein purification solutions, and more.